HOBOKEN, New Jersey, May 6 -- Diabetes, Obesity and Metabolism, a journal that says it focuses on clinical and experimental pharmacology and therapeutics in any aspect of metabolic and endocrine disease, either in humans or animal and cellular systems, published research articles, including the following topics, in its June 2023 edition:

REVIEW ARTICLES:

* Nonalcoholic fatty liver disease from a primary care perspective

* Change in albuminuria as a surroga . . .

Click here for more information about our products